Lantheus Holdings (LNTH) Gross Profit Growth (3y) (2017 - 2026)
Lantheus Holdings (LNTH) Gross Profit Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.82 Bn | 87.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.03 Bn | 32.29 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.02 Bn | 20.86 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.63 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn | 0.95% |
| 10 | Lantheus Holdings | 7.03 Bn | 6.53 Bn | 230.92 Mn | 44.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.16% |
| Dec 31, 2025 | 12.95% |
| Sep 30, 2025 | 14.68% |
| Jun 30, 2025 | 20.42% |
| Mar 31, 2025 | 22.57% |
| Dec 31, 2024 | 62.51% |
| Sep 30, 2024 | 78.37% |
| Jun 30, 2024 | 77.05% |
| Mar 31, 2024 | 80.64% |
| Dec 31, 2023 | 81.18% |
| Sep 30, 2023 | 76.67% |
| Jun 30, 2023 | 98.66% |
| Mar 31, 2023 | 26.58% |
| Dec 31, 2022 | 55.38% |
| Sep 30, 2022 | 52.48% |
| Jun 30, 2022 | 45.76% |
| Mar 31, 2022 | 43.06% |
| Dec 31, 2021 | 9.72% |
| Sep 30, 2021 | -1.67% |
| Jun 30, 2021 | 1.68% |